Actively Recruiting
Screening for Early Gastric Cancer in Shaanxi Province
Led by Second Affiliated Hospital of Xi'an Jiaotong University · Updated on 2022-03-23
12500000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational study to screen for early gastric cancer among local residents aged over 20 years in 11 regions of Shaanxi Province. The study aims to evaluate the prevalence of dyspepsia, gastroesophageal reflux disease, precancerous lesions, and Helicobacter pylori infection in this natural population. A new gastric cancer risk assessment model will be developed based on the collected data. Participants provide basic information through questionnaires covering social demographics, lifestyle, and medical history. Serum Helicobacter pylori antibody tests are also performed. The expert group then identifies individuals at high risk for gastric cancer, who, if they have no contraindications, undergo electronic gastroscopy in designated hospitals after informed consent. Throughout the study, data on symptoms, infections, treatments, and recurrence rates are collected and analyzed. The primary outcome is the detection rate of early gastric cancer over the six-year period from October 2020 to October 2026. Secondary outcomes include the prevalence of digestive conditions and infection rates. This comprehensive approach helps understand risk factors and disease prevalence in the population.
CONDITIONS
Brief Title
Screening for Early Gastric Cancer in Shaanxi Province
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Local resident over 20 years old
- Provided verbal informed consent to participate
You will not qualify if you...
- Refused to participate in this research project
- Did not complete questionnaires or serological tests for Helicobacter pylori antibodies
- Study participation was not completed due to other reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From October 2020 to October 2026
Participants complete questionnaires about their social and health background and undergo serological testing for Helicobacter pylori antibodies. High-risk participants undergo electronic gastroscopy in designated hospitals.
Questionnaire and blood test at 1 visit; gastroscopy for high-risk participants (1 visit in-person)
Duration - From October 2020 to October 2026
Participants are observed for the prevalence of digestive diseases and outcomes related to Helicobacter pylori infection, including treatment and recurrence rates.
Data collected periodically during the study period
Trial Site Locations
Total: 1 location
1
The second affiliated hospital of xi'an jiaotong university
Xi'an, Shaanxi, China, 710004
Actively Recruiting
Research Team
J
jinhai Wang, MD
R
Rui Wang, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here